Laparoscopic and robotic resection for pancreatic cancer

Michael L. Kendrick

Research output: Contribution to journalReview article

63 Citations (Scopus)

Abstract

Minimally invasive surgical approaches for pancreatic resection have been established as feasible and safe. Whereas widespread application of laparoscopic distal pancreatectomy is in progress, the utilization of laparoscopic pancreaticoduodenectomy is still localized to a few centers because of the added complexity and advanced laparoscopic skills required. Comparative studies have demonstrated the typical advantages of minimally invasive approaches for pancreatic resection, namely, less blood loss and shorter hospital stay. Robotic assistance for laparoscopic approaches is gaining interest, but the true value added is still undefined. Significant discussion revolves around the appropriateness of minimally invasive approaches in pancreatic cancer. Although limited data and only short-term follow-up engender ongoing skepticism, the technical feasibility, existing reports in pancreatic cancer, and the lack of negative outcomes in other gastrointestinal cancers spark ongoing clinical evaluation. Minimally invasive surgical approaches have significant potential to improve the outcomes of pancreatic resection especially in pancreatic cancer patients in whom an optimal recovery is important for adjuvant treatment options. Larger experiences are forthcoming, and controlled trials are eagerly awaited; however, the feasibility of such is questionable because of the low incidence of resectable pancreatic cancer and the small number of centers performing minimally invasive pancreatectomy for malignancy.

Original languageEnglish (US)
Pages (from-to)571-576
Number of pages6
JournalCancer Journal (United States)
Volume18
Issue number6
DOIs
StatePublished - Nov 2012

Fingerprint

Robotics
Pancreatic Neoplasms
Pancreatectomy
Gastrointestinal Neoplasms
Pancreaticoduodenectomy
Length of Stay
Incidence
Neoplasms
Therapeutics

Keywords

  • laparoscopic distal pancreatectomy
  • Pancreatic cancer
  • robotic resection

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Laparoscopic and robotic resection for pancreatic cancer. / Kendrick, Michael L.

In: Cancer Journal (United States), Vol. 18, No. 6, 11.2012, p. 571-576.

Research output: Contribution to journalReview article

Kendrick, Michael L. / Laparoscopic and robotic resection for pancreatic cancer. In: Cancer Journal (United States). 2012 ; Vol. 18, No. 6. pp. 571-576.
@article{65e8defd475b42adae30d9fb4787b483,
title = "Laparoscopic and robotic resection for pancreatic cancer",
abstract = "Minimally invasive surgical approaches for pancreatic resection have been established as feasible and safe. Whereas widespread application of laparoscopic distal pancreatectomy is in progress, the utilization of laparoscopic pancreaticoduodenectomy is still localized to a few centers because of the added complexity and advanced laparoscopic skills required. Comparative studies have demonstrated the typical advantages of minimally invasive approaches for pancreatic resection, namely, less blood loss and shorter hospital stay. Robotic assistance for laparoscopic approaches is gaining interest, but the true value added is still undefined. Significant discussion revolves around the appropriateness of minimally invasive approaches in pancreatic cancer. Although limited data and only short-term follow-up engender ongoing skepticism, the technical feasibility, existing reports in pancreatic cancer, and the lack of negative outcomes in other gastrointestinal cancers spark ongoing clinical evaluation. Minimally invasive surgical approaches have significant potential to improve the outcomes of pancreatic resection especially in pancreatic cancer patients in whom an optimal recovery is important for adjuvant treatment options. Larger experiences are forthcoming, and controlled trials are eagerly awaited; however, the feasibility of such is questionable because of the low incidence of resectable pancreatic cancer and the small number of centers performing minimally invasive pancreatectomy for malignancy.",
keywords = "laparoscopic distal pancreatectomy, Pancreatic cancer, robotic resection",
author = "Kendrick, {Michael L.}",
year = "2012",
month = "11",
doi = "10.1097/PPO.0b013e31827b8f86",
language = "English (US)",
volume = "18",
pages = "571--576",
journal = "Cancer Journal (United States)",
issn = "1528-9117",
publisher = "Association Pour le Developpement de la Communication Cancerologique",
number = "6",

}

TY - JOUR

T1 - Laparoscopic and robotic resection for pancreatic cancer

AU - Kendrick, Michael L.

PY - 2012/11

Y1 - 2012/11

N2 - Minimally invasive surgical approaches for pancreatic resection have been established as feasible and safe. Whereas widespread application of laparoscopic distal pancreatectomy is in progress, the utilization of laparoscopic pancreaticoduodenectomy is still localized to a few centers because of the added complexity and advanced laparoscopic skills required. Comparative studies have demonstrated the typical advantages of minimally invasive approaches for pancreatic resection, namely, less blood loss and shorter hospital stay. Robotic assistance for laparoscopic approaches is gaining interest, but the true value added is still undefined. Significant discussion revolves around the appropriateness of minimally invasive approaches in pancreatic cancer. Although limited data and only short-term follow-up engender ongoing skepticism, the technical feasibility, existing reports in pancreatic cancer, and the lack of negative outcomes in other gastrointestinal cancers spark ongoing clinical evaluation. Minimally invasive surgical approaches have significant potential to improve the outcomes of pancreatic resection especially in pancreatic cancer patients in whom an optimal recovery is important for adjuvant treatment options. Larger experiences are forthcoming, and controlled trials are eagerly awaited; however, the feasibility of such is questionable because of the low incidence of resectable pancreatic cancer and the small number of centers performing minimally invasive pancreatectomy for malignancy.

AB - Minimally invasive surgical approaches for pancreatic resection have been established as feasible and safe. Whereas widespread application of laparoscopic distal pancreatectomy is in progress, the utilization of laparoscopic pancreaticoduodenectomy is still localized to a few centers because of the added complexity and advanced laparoscopic skills required. Comparative studies have demonstrated the typical advantages of minimally invasive approaches for pancreatic resection, namely, less blood loss and shorter hospital stay. Robotic assistance for laparoscopic approaches is gaining interest, but the true value added is still undefined. Significant discussion revolves around the appropriateness of minimally invasive approaches in pancreatic cancer. Although limited data and only short-term follow-up engender ongoing skepticism, the technical feasibility, existing reports in pancreatic cancer, and the lack of negative outcomes in other gastrointestinal cancers spark ongoing clinical evaluation. Minimally invasive surgical approaches have significant potential to improve the outcomes of pancreatic resection especially in pancreatic cancer patients in whom an optimal recovery is important for adjuvant treatment options. Larger experiences are forthcoming, and controlled trials are eagerly awaited; however, the feasibility of such is questionable because of the low incidence of resectable pancreatic cancer and the small number of centers performing minimally invasive pancreatectomy for malignancy.

KW - laparoscopic distal pancreatectomy

KW - Pancreatic cancer

KW - robotic resection

UR - http://www.scopus.com/inward/record.url?scp=84871181209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871181209&partnerID=8YFLogxK

U2 - 10.1097/PPO.0b013e31827b8f86

DO - 10.1097/PPO.0b013e31827b8f86

M3 - Review article

C2 - 23187844

AN - SCOPUS:84871181209

VL - 18

SP - 571

EP - 576

JO - Cancer Journal (United States)

JF - Cancer Journal (United States)

SN - 1528-9117

IS - 6

ER -